[Coagulopathy in COVID-19: pathophysiology]. / La coagulopatia nel COVID-19: basi fisiopatologiche.
G Ital Cardiol (Rome)
; 21(7): 483-488, 2020 Jul.
Article
in Italian
| MEDLINE | ID: covidwho-611790
ABSTRACT
On March 11, 2020, just after 2 months from the first cases of coronavirus disease 2019 (COVID-19) in China, the Director-General of the World Health Organization stated that COVID-19 has to be considered as a pandemic. Italian doctors were the first protagonists, after the Chinese ones, in the management of this disease. Clinical observations showed that, in addition to the respiratory infection, a systemic inflammatory response occurs, which leads to coagulation disorders and consequent venous thromboembolism as well as other thrombotic complications. We here review the available literature on this issue to better understand the pathophysiological mechanisms of coagulopathy useful to draw future clinical and therapeutic conclusions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Viremia
/
Blood Coagulation Disorders
/
Coronavirus Infections
/
Venous Thromboembolism
/
Pandemics
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Europa
Language:
Italian
Journal:
G Ital Cardiol (Rome)
Journal subject:
Cardiology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS